0
0
Montreal, June 3: Vaccines could play a vital role in protecting children and adolescents from hearing loss, according to a new study that has identified 26 infectious pathogens linked to auditory damage. The research, conducted by a team including experts from Université de Montréal, highlights the often-overlooked benefits of immunization beyond preventing life-threatening diseases.
Globally, more than 1.5 billion people experience some degree of hearing loss, a condition frequently associated with aging. However, a significant proportion of cases originate from infections contracted during childhood—many of which are preventable through timely vaccination. The World Health Organization (WHO) estimates that nearly 60% of childhood hearing loss could be avoided with effective public health interventions, especially immunization against diseases such as rubella and certain forms of meningitis.
Pathogens Linked to Hearing Loss
Published in the journal Communications Medicine, the study provides a comprehensive review of scientific literature, listing 26 viruses and bacteria capable of causing hearing impairment. Among the most notable are:
-
Measles virus
-
Rubella virus: Particularly dangerous if contracted during pregnancy, as it can lead to congenital deafness.
-
Mumps virus: Known to damage the inner ear or auditory nerve.
-
Bacterial agents: Including Haemophilus influenzae, Streptococcus pneumoniae, and Neisseria meningitidis, all of which can cause meningitis that may result in irreversible hearing loss.
Expanding the Benefits of Vaccination
Professor Mira Johri of Université de Montréal’s School of Public Health emphasized the broader advantages of vaccines: “If a vaccine is shown to save lives, it’s reasonable for policy decisions to be made on that basis. But vaccines can also offer significant benefits in preventing other harms, such as hearing loss, and these benefits deserve greater attention.”
The researchers advocate for the inclusion of hearing loss risk in vaccine policy evaluations—not only during the development phase but also in post-market assessments. Factoring in these additional benefits could help guide future research and innovation in vaccine formulation, ultimately leading to more comprehensive public health strategies.
Disclaimer:
This article is based on recent scientific research and expert commentary. While vaccines have been shown to prevent certain infections associated with hearing loss, individual medical decisions should always be made in consultation with qualified healthcare professionals. The findings described here are for informational purposes and should not be considered a substitute for professional medical advice.
